NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Thanks for the detailed answer biosectinvestor. I believe there was evidence presented in this board and discussion about Germany wanting some sort of an automated process for the manufacture of DCVax-L. Something like that. Anyway, if Germany wanted a sort of second generation of the manufacturing, and then received it, why would they then halt enrollment in the trial? If the trial had completed enrollment and added the 17 additional patients, I’m thinking that would have possibly lessened the waiting time we’re experiencing here.